FDA Oncology Announcements

EGFR inhibitor × Other × Clear all

6 Announcements

Erlotinib (Tarceva)

Drug: TARCEVA (erlotinib) · EGFR inhibitor

Osimertinib

Drug: TAGRISSO (osimertinib) · EGFR inhibitor

Gefitinib (Iressa)

Drug: IRESSA (gefitinib) · EGFR inhibitor

FDA Approves Afatinib

Drug: Gilotrif tablets (afatinib) · EGFR inhibitor

FDA Approves Erlotinib

Drug: Tarceva (erlotinib) · EGFR inhibitor

Erlotinib

Drug: Tarceva (erlotinib) · EGFR inhibitor